Literature DB >> 16891504

Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance.

Michael B Townsend1, Erica D Dawson, Martin Mehlmann, James A Smagala, Daniela M Dankbar, Chad L Moore, Catherine B Smith, Nancy J Cox, Robert D Kuchta, Kathy L Rowlen.   

Abstract

Global surveillance of influenza is critical for improvements in disease management and is especially important for early detection, rapid intervention, and a possible reduction of the impact of an influenza pandemic. Enhanced surveillance requires rapid, robust, and inexpensive analytical techniques capable of providing a detailed analysis of influenza virus strains. Low-density oligonucleotide microarrays with highly multiplexed "signatures" for influenza viruses offer many of the desired characteristics. However, the high mutability of the influenza virus represents a design challenge. In order for an influenza virus microarray to be of utility, it must provide information for a wide range of viral strains and lineages. The design and characterization of an influenza microarray, the FluChip-55 microarray, for the relatively rapid identification of influenza A virus subtypes H1N1, H3N2, and H5N1 are described here. In this work, a small set of sequences was carefully selected to exhibit broad coverage for the influenza A and B viruses currently circulating in the human population as well as the avian A/H5N1 virus that has become enzootic in poultry in Southeast Asia and that has recently spread to Europe. A complete assay involving extraction and amplification of the viral RNA was developed and tested. In a blind study of 72 influenza virus isolates, RNA from a wide range of influenza A and B viruses was amplified, hybridized, labeled with a fluorophore, and imaged. The entire analysis time was less than 12 h. The combined results for two assays provided the absolutely correct types and subtypes for an average of 72% of the isolates, the correct type and partially correct subtype information for 13% of the isolates, the correct type only for 10% of the isolates, false-negative signals for 4% of the isolates, and false-positive signals for 1% of the isolates. In the overwhelming majority of cases in which incomplete subtyping was observed, the failure was due to the nucleic acid amplification step rather than limitations in the microarray.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891504      PMCID: PMC1594652          DOI: 10.1128/JCM.00134-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

Review 1.  Influenza.

Authors:  D Stamboulian; P E Bonvehí; F M Nacinovich; N Cox
Journal:  Infect Dis Clin North Am       Date:  2000-03       Impact factor: 5.982

Review 2.  Multiplex PCR: optimization and application in diagnostic virology.

Authors:  E M Elnifro; A M Ashshi; R J Cooper; P E Klapper
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  Optimization of fragmentation conditions for microarray analysis of viral RNA.

Authors:  Martin Mehlmann; Michael B Townsend; Robin L Stears; Robert D Kuchta; Kathy L Rowlen
Journal:  Anal Biochem       Date:  2005-10-17       Impact factor: 3.365

4.  Typing and subtyping influenza virus using DNA microarrays and multiplex reverse transcriptase PCR.

Authors:  J Li; S Chen; D H Evans
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Robust sequence selection method used to develop the FluChip diagnostic microarray for influenza virus.

Authors:  Martin Mehlmann; Erica D Dawson; Michael B Townsend; James A Smagala; Chad L Moore; Catherine B Smith; Nancy J Cox; Robert D Kuchta; Kathy L Rowlen
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Evaluation of uranyl photocleavage as a probe to monitor ion binding and flexibility in RNAs.

Authors:  D Wittberger; C Berens; C Hammann; E Westhof; R Schroeder
Journal:  J Mol Biol       Date:  2000-07-07       Impact factor: 5.469

7.  Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003.

Authors:  K M Butt; Gavin J D Smith; Honglin Chen; L J Zhang; Y H Connie Leung; K M Xu; Wilina Lim; Robert G Webster; K Y Yuen; J S Malik Peiris; Yi Guan
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 8.  Pandemic threat posed by avian influenza A viruses.

Authors:  T Horimoto; Y Kawaoka
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

9.  Evaluation of a neuraminidase detection assay for the rapid detection of influenza A and B virus in children.

Authors:  D E Noyola; A J Paredes; B Clark; G J Demmler
Journal:  Pediatr Dev Pathol       Date:  2000 Mar-Apr

10.  Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

Authors:  Y P Lin; M Shaw; V Gregory; K Cameron; W Lim; A Klimov; K Subbarao; Y Guan; S Krauss; K Shortridge; R Webster; N Cox; A Hay
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

View more
  52 in total

Review 1.  Methods for molecular surveillance of influenza.

Authors:  Ruixue Wang; Jeffery K Taubenberger
Journal:  Expert Rev Anti Infect Ther       Date:  2010-05       Impact factor: 5.091

2.  Differentiation of the seven major lyssavirus species by oligonucleotide microarray.

Authors:  Jin Xi; Huancheng Guo; Ye Feng; Yunbin Xu; Mingfu Shao; Nan Su; Jiayu Wan; Jiping Li; Changchun Tu
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

3.  Rapid differentiation of influenza A virus subtypes and genetic screening for virus variants by high-resolution melting analysis.

Authors:  Jih-Hui Lin; Ching-Ping Tseng; Yen-Ju Chen; Chy-Yung Lin; Shy-Shin Chang; Ho-Sheng Wu; Ju-Chien Cheng
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

4.  Subtyping of avian influenza viruses H1 to H15 on the basis of hemagglutinin genes by PCR assay and molecular determination of pathogenic potential.

Authors:  Kenji Tsukamoto; Hisayoshi Ashizawa; Koji Nakanishi; Noriyuki Kaji; Kotaro Suzuki; Masatoshi Okamatsu; Shigeo Yamaguchi; Masaji Mase
Journal:  J Clin Microbiol       Date:  2008-07-02       Impact factor: 5.948

Review 5.  Basic concepts of microarrays and potential applications in clinical microbiology.

Authors:  Melissa B Miller; Yi-Wei Tang
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

6.  Preparation of Silicon Nanowire Field-effect Transistor for Chemical and Biosensing Applications.

Authors:  Jennifer Yun-Shin Wu; Chih-Heng Lin; Mei-Huei Feng; Chien-Hung Chen; Ping-Chia Su; Po-Wen Yang; Jian-Ming Zheng; Chang-Wei Fu; Yuh-Shyong Yang
Journal:  J Vis Exp       Date:  2016-04-21       Impact factor: 1.355

7.  Multiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray.

Authors:  Ying Huang; Huong Tang; Stuart Duffy; Yuwen Hong; Sylvia Norman; Madhu Ghosh; Jie He; Michael Bose; Kelly J Henrickson; Jiang Fan; Andrea J Kraft; William G Weisburg; Elizabeth L Mather
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

Review 8.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Design and validation of a microarray for detection, hemagglutinin subtyping, and pathotyping of avian influenza viruses.

Authors:  Astrid Gall; Bernd Hoffmann; Timm Harder; Christian Grund; Dirk Höper; Martin Beer
Journal:  J Clin Microbiol       Date:  2008-12-03       Impact factor: 5.948

10.  A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America.

Authors:  Alexander L Greninger; Eunice C Chen; Taylor Sittler; Alex Scheinerman; Nareg Roubinian; Guixia Yu; Edward Kim; Dylan R Pillai; Cyril Guyard; Tony Mazzulli; Pavel Isa; Carlos F Arias; John Hackett; Gerald Schochetman; Steve Miller; Patrick Tang; Charles Y Chiu
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.